
A "supercharged" fibre that mimics Ozempic's hunger hormones just cleared EU food safety review
The Core Issue
Most people eat nowhere near the 25 to 30 grams of fiber recommended daily. And to meaningfully stimulate the gut hormones that suppress appetite, you'd typically need around 80 grams. That's not realistic for anyone.
The Finding
Researchers spent 15 years developing IPE (inulin-propionate ester), a modified fibre that delivers propionate, a gut-signaling fatty acid, directly to the large intestine. Just 10 grams a day appears to trigger the release of GLP-1 and PYY, the same hunger-suppressing hormones that Ozempic-style drugs artificially mimic. The European Commission officially authorized IPE for food use on June 9, 2026.
Why It Matters
This isn't a drug. It's a food ingredient that could show up in your smoothie or cereal bar within the next year. In one trial, none of the middle-aged participants taking IPE gained significant weight over six months, compared to 17% of the control group. A separate year-long trial in younger adults found an average increase of over a kilogram of fat-free body mass.
Limitations of Study
The weight-gain prevention trial in people over 40 was small. The fat-free mass finding in younger participants also couldn't confirm whether the gain was muscle specifically or other non-fat tissue. One outside researcher describes the overall evidence as mixed. The approval currently covers only the EU, and UK authorization is not yet in place.
Interesting Statistics
• 10g per day is the studied dose, a fraction of the 80g traditionally needed to stimulate appetite hormones through diet alone • 0% of the IPE group in one trial gained significant weight over 6 months vs. 17% of controls • Over 1 kg of fat-free mass gained on average in a year-long trial of younger overweight adults • EU approval allows up to 17g per 100g in cereal bars and up to 3g per 100ml in fruit smoothies • Imperial College holds exclusive EU market protection until June 30, 2031 • 12 years to secure European Food Safety Authority approval • Products are expected to reach EU shelves within 12 months
Useful Takeaways
IPE is framed as a preventive tool, not a weight-loss drug. Researchers are now exploring whether it could help people preserve muscle while on GLP-1 medications, or slow weight regain after stopping them. The only reported side effect is increased flatulence, which is standard territory for high-fibre intake.
TL;DR
A modified fibre called IPE triggers the same gut hormones as Ozempic at just 10 grams a day and is now approved for use in EU food products, with smoothies and cereal bars potentially on shelves within a year.